Long-term outcome of hepatitis B e antig
β
G Fattovich; G Giustina; G Realdi; R Corrocher; S W Schalm
π
Article
π
1997
π
John Wiley and Sons
π
English
β 189 KB
π 1 views
The aim of this study was to evaluate whether interferon alfa (IFN-alpha) treatment-associated virological and biochemical remission improves survival in a cohort of 90 white patients with compensated cirrhosis caused by hepatitis B (Child A) followed for a mean period of 7 years. Inclusion criteria